• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS CORPORATION TRAPEASE PVCF FEM/JUG 55CM CSI; FILTER, INTRAVASCULAR, CARDIOVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS CORPORATION TRAPEASE PVCF FEM/JUG 55CM CSI; FILTER, INTRAVASCULAR, CARDIOVASCULAR Back to Search Results
Model Number 466P306AU
Device Problem Fracture (1260)
Patient Problems Coagulation Disorder (1779); Stenosis (2263); Obstruction/Occlusion (2422)
Event Date 01/31/2020
Event Type  Injury  
Manufacturer Narrative
As reported by the legal brief, a patient underwent placement of a trapease vena cava filter.The filter subsequently malfunctioned and caused injury and damage to the patient, including, but not limited to, specific evidence that the filter has two fractured struts and there is high grade stenosis of the inferior vena cava (ivc).As a direct and proximate result of these malfunctions, the patient has suffered life threatening injuries and damages and required extensive medical care and treatment.As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering and other damages.The device was not returned for analysis.No lot number was provided therefore a product history record (phr) review could not be generated.The reported ¿filter-tilt, filter-fractured - in patient and inferior vena cava stenosis¿ could not be confirmed as the device was not returned for analysis.The exact cause of the reported events could not be conclusively determined.Procedural/handling factors, or vessel characteristics, although unknown, may have contributed to the reported event.According to the ifu, which is not intended as a mitigation of risk, filter fracture is a potential complication of vena cava filters.Anatomic locations that create concentrated stress points from filter deformation (for example, deployment at apex of scoliosis, overlapping of either of the renal ostia, or placement adjacent to a vertebral osteophyte) may contribute to fracture of a particular filter strut.However, reports of adverse clinical sequelae from filter fractures are rare.Without images available for review the reported events could not be confirmed or further clarified.As no lot number or other product information was supplied a phr could not be completed.The little information available does not suggest a design or manufacturing related cause for the reported event; therefore, no corrective/preventive action will be taken at this time.Should additional information become available, the file will be updated accordingly.
 
Event Description
As reported by the legal brief, a patient underwent placement of a trapease vena cava filter.The filter subsequently malfunctioned and caused injury and damage to the patient, including, but not limited to specific evidence that the filter has two fractured struts and there is high grade stenosis of the inferior vena cava (ivc).As a direct and proximate result of these malfunctions, the patient has suffered life threatening injuries and damages, and required extensive medical care and treatment.As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering and other damages.
 
Event Description
Additional information received per the medical records indicate that the patient has a history of obesity, chronic anxiety, gastroesophageal reflux disease, hypertension, mood disorder, right lung nodule, insomnia, right knee arthroscopy and meniscal repair.The indication for the filter implant was extensive thrombosis of the right popliteal vein, and bilateral pulmonary emboli.The filter was placed via the right internal jugular vein and deployed at the junction of the third and fourth lumbar vertebral bodies above the bifurcation, but below the renal veins.Approximately seven months post implant a follow up bilateral lower extremity (ble) ultrasound (u/s) was performed and showed no evidence of deep vein thrombosis (dvt).Approximately four years and four months post implant a right lower extremity u/s was performed for leg pain and was negative for dvt.Additional information received per the patient profile form (ppf) states that the patient experienced filter fracture.The patient became aware of the reported events approximately thirteen years and one month after the index procedure.The patient also reported tiredness, body aches and pains (knees, flank, legs), palpitations, shortness of breath, leg and feet swelling with discoloration of the right leg and foot, bladder incontinence, 95% occlusion of the fractured ivc filter, blood clots in both legs and the abdomen, pain following unspecified surgical procedures, left heel numbness and pain, anxiety, depression, and posttraumatic stress disorder (ptsd) related to the filter.
 
Manufacturer Narrative
After further review of additional information received, the following sections have been updated accordingly: as reported a patient underwent placement of a trapease vena cava filter.The information provided indicated that the filter subsequently malfunctioned and caused fracture of 2 filter struts and stenosis.The patient reported becoming aware of filter fracture approximately thirteen years and one month post implant.The patient also reported tiredness, body aches and pains (knees, flank, legs), palpitations, shortness of breath, leg and feet swelling with discoloration of the right leg and foot, bladder incontinence, 95% occlusion of the fractured ivc filter, blood clots in both legs and the abdomen, pain following unspecified surgical procedures, left heel numbness and pain, and posttraumatic stress disorder related to the filter.According to the medical record the patient had a history of obesity, chronic anxiety, gastroesophageal reflux disease, hypertension, mood disorder, right lung nodule, insomnia, right knee arthroscopy and meniscal repair.The indication for the filter was extensive thrombosis of the right popliteal vein, and bilateral pulmonary emboli.The filter was placed via the right internal jugular vein and deployed at the junction of the third and fourth lumbar vertebral bodies above the bifurcation, but below the renal veins.Approximately seven months post implant a follow up bilateral lower extremity (ble) ultrasound (u/s) was performed and showed no evidence of deep vein thrombosis (dvt).Approximately four years and four months post implant a right lower extremity u/s was performed for leg pain and was negative for dvt.The product remains implant and therefore not available for analysis.A review of the device history record revealed no anomalies during the manufacturing and inspection processes that can be associated with the reported complaint.The trapease ivc filter is indicated for use in the prevention of recurrent pulmonary embolism (pe) via percutaneous placement in the vena cava for patients in which anticoagulants are contraindicated, anticoagulant therapy for thromboembolic disease has failed, emergency treatment following massive pe where anticipated benefits of conventional therapy are reduced or for chronic, recurrent pe where anticoagulant therapy has failed, or is contraindicated.The purpose of a vena cava filter is to catch thrombus from the lower extremities as it travels along normal blood flow patterns up towards the heart.Blood clots, clotting, stenosis (abnormal narrowing of a vessel), thrombosis and/or occlusion within the device or the vasculature do not represent a device malfunction.Clinical factors that may have influenced the event include patient, pharmacological and vessel characteristics.The instructions for use (ifu) states that filter fracture is a potential complication of vena cava filters.Anatomic locations that create concentrated stress points from filter deformation (for example, deployment at apex of scoliosis, overlapping of either of the renal ostia, or placement adjacent to a vertebral osteophyte) may contribute to fracture of a particular filter strut.The timing and mechanism of the reported events has not been reported at this time and a clinical conclusion could not be determined as to the cause of the event.Without procedural films or post implant imaging available for review, the reported events could not be confirmed or further clarified.Shortness of breath, pain, palpitations, being tired and incontinence do not represent a device malfunction and may be related to underlying patient specific issues or comorbidities.There is nothing to suggest that the reported event is related to the design and/or manufacturing process of the device; therefore, no corrective action will be taken.Should additional information become available, the file will be updated accordingly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRAPEASE PVCF FEM/JUG 55CM CSI
Type of Device
FILTER, INTRAVASCULAR, CARDIOVASCULAR
Manufacturer (Section D)
CORDIS CORPORATION
14201 nw 60th ave
miami lakes FL 33014 2802
Manufacturer (Section G)
CORDIS CORPORATION
14201 nw 60th ave
miami lakes FL 33014 2802
Manufacturer Contact
karla castro
14201 nw 60th ave
miami lakes, FL 33014-2802
7863138372
MDR Report Key12259690
MDR Text Key264523447
Report Number1016427-2021-05170
Device Sequence Number1
Product Code DTK
UDI-Device Identifier20705032009451
UDI-Public20705032009451
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K020316
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 06/15/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/02/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number466P306AU
Device Catalogue Number466P306AU
Device Lot NumberR1006216
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received05/20/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/23/2006
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening;
Patient Age49 YR
Patient SexFemale
-
-